Perspective Therapeutics Inc (CATX)
R&D Expenses
$21.54M
Quarterly · Period ending: · USD
CATX R&D Expenses
Latest reported$21.54Mperiod ending
Latest reported$21.54Mperiod ending
CATX Quarterly R&D Expenses ($0.00 → $21.54M)
Quarterly R&D Expenses
High-resolution chart · PNG
CATX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 21,544,000 | |
| 20,246,000 | |
| 32,924,000 | |
| 20,339,000 | |
| 12,174,000 | |
| 11,359,000 | |
| 12,883,000 | |
| 12,028,000 | |
| 7,452,000 | |
| 5,353,000 | |
| 6,080,000 | |
| 5,653,000 | |
| 5,370,000 | |
| 3,857,000 | |
| 613,000 | |
| 708,000 | |
| 796,000 | |
| 549,000 | |
| 535,000 | |
| 702,000 | |
| 468,000 | |
| 362,000 | |
| 285,000 | |
| 312,000 | |
| 322,000 | |
| 294,000 | |
| 277,000 | |
| 233,000 | |
| 341,000 | |
| 299,000 | |
| 414,000 | |
| 420,000 | |
| 572,000 | |
| 473,000 | |
| 340,000 | |
| 362,000 | |
| 316,000 | |
| 327,000 | |
| 150,000 | |
| 172,000 | |
| 142,724 | |
| 183,187 | |
| 58,235 | |
| 143,903 | |
| 156,135 | |
| 141,399 | |
| 140,627 | |
| 176,610 | |
| 198,172 | |
| 153,611 | |
| 170,030 | |
| 146,990 | |
| 181,322 | |
| 155,137 | |
| 149,176 | |
| 141,472 | |
| 207,367 | |
| 132,237 | |
| 189,661 | |
| 201,314 | |
| 296,963 | |
| 188,066 | |
| 15,612 | |
| 114,522 | |
| 114,035 | |
| 98,964 | |
| 59,078 | |
| 68,882 | |
| 132,152 | |
| 301,907 | |
| 306,056 | |
| 218,550 | |
| 271,742 | |
| 434,418 | |
| 395,545 | |
| 256,370 | |
| 446,168 | |
| 437,143 | |
| 216,254 | |
| 245,598 | |
| 241,612 | |
| 86,194 | |
| 96,837 | |
| 25,782 | |
| 25,782 | |
| 80,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |